Space Stocks Coast Through SpaceX Q3 Print: Rocket Lab, Firefly Steady
SpaceX beat Q3 revenue and earnings estimates, fueled by surging AI and Starlink growth, while space-sector peers saw muted gains.
Modal taps Nvidia Vera CPUs after firm's internal tests show 2x throughput over Intel and AMD chips — AI agentic workflows said to favor Arm chips, but firm will keep x86 chips deployed in heterogeneous server fleet
Modal taps Nvidia Vera CPUs after firm's internal tests show 2x throughput over Intel and AMD chips — AI agentic workflows said to favor Arm chips, but firm will keep x86 chips deployed in heterogeneous server fleet（摘要待生成）
Analyzing Analog Devices In Comparison To Competitors In Semiconductors & Semiconductor Equipment Industry
In today's fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry
GE Aerospace reports Q3 growth and raises full-year guidance
On October 20, GE Aerospace reported Q3 orders of $19.0 billion (+49%), adjusted revenue of $13.3 billion (+18%) and adjusted EPS of $2.25 (+36%), and raised 2026 guidance. It cited double-digit year-over-year increases in material input from priority suppliers.
Halliburton posts Q3 results; North America revenue declines
On Oct. 20, competitor Halliburton reported Q3 revenue of $5.7 billion, flat sequentially, and adjusted EPS of $0.60. North America revenue fell 5% sequentially to $2.2 billion, primarily on lower U.S. Land pressure pumping; Middle East/Asia revenue rose 8% to $1.4 billion.
Jefferies downgraded Zoetis and Elanco, citing animal-health pricing risks; reiterated Buy on IDEXX
On October 20, Jefferies cut Zoetis and Elanco to Hold from Buy, citing pricing risk, muted vet visits, mid-single-digit vet-labor inflation and waning owner sentiment; it said price and mix account for all growth in vet and pet services, versus 50%–65% pre-pandemic. Jefferies reiterated Buy on IDEXX. ([uk.investing.com](https://uk.investing.com/news/stock-market-news/jefferies-downgrades-zoetis-e
WELL Health Appoints Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory
WELL Health Technologies Corp. has appointed Samara Starkman to lead its enterprise privacy, AI governance, and healthcare regulatory strategy.
Jefferies cuts IDEXX target to $705 from $795; contrasts with Zoetis and Elanco cuts
On Oct. 20, 2026, Jefferies reiterated Buy on IDEXX and cut its target to $705 from $795. The same day, analyst Keith Devas downgraded Zoetis and Elanco to Hold from Buy, cutting targets to $83 from $103 and $24 from $31, respectively; he cited veterinary-sector pricing-power risks.
微软董事长萨提亚·纳德拉：造芯、上云，与重回4万亿美元的十二年丨【商业人物档案】
微软董事长萨提亚·纳德拉：造芯、上云，与重回4万亿美元的十二年丨【商业人物档案】（摘要待生成）
Apollo Global Management, 8-K (5.02, 7.01, 9.01): director or officer change
Apollo appointed Ribbit Capital founder and managing partner Meyer “Micky” Malka to its board effective January 1, 2027, increasing the board to 14 directors while maintaining two-thirds independence.
Aehr Test Systems 8-K (5.07): shareholder vote results
Aehr Test Systems reported that shareholders elected all six director nominees, ratified BPM LLP as its independent auditor for the fiscal year ending June 25, 2027, and approved executive compensation in a non-binding advisory vote.
Susquehanna raises EOG price target to $187, keeps Positive rating
On October 20, 2026, Susquehanna analyst Biju Perincheril raised the price target from $170 to $187 and maintained a Positive rating.
Susquehanna raises Occidental target to $77 from $70
On October 20, 2026, Susquehanna analyst Charles Minervino raised the target to $77 from $70 and maintained Positive. For its Q3 preview, the firm raised its 2026 oil-price assumption to $84/bbl from $80, citing higher Q3 pricing and Strait of Hormuz disruptions; it slightly lowered its 2026 natural-gas assumption.
UBS raises Schrödinger price target to $21 from $19; keeps Neutral
On Oct. 20, UBS analyst Kevin Caliendo maintained Neutral and raised the target to $21 from $19.
Sarah Cannon Research Institute at HCA Healthcare to Present Clinical Trial Data
The Sarah Cannon Research Institute (SCRI) at HCA Healthcare announced upcoming presentations of clinical trial results for oncology treatments at an industry event.
J.P. Morgan reinstated Hubbell at Neutral with $485 target
Event: October 20, 2026. Julian Mitchell of J.P. Morgan initiated coverage at Hold/Neutral with a $485 price target.
Deutsche Bank Downgrades Ferrovial to Hold
Deutsche Bank has downgraded its rating for Ferrovial from Buy to Hold.
Reuters poll sees Fed holding rates October 27–28; all respondents expect December hike
Published October 20. In Reuters’ October 16–20 poll, 94 of 100 economists expected the Fed to hold at 3.75%–4.00% on October 27–28, while all 100 expected a December hike. Reuters reported longer-dated Treasury yields had reached multi-decade highs October 7 before retreating nearly 25 basis points as October-hike expectations faded.
Centene shares rise 3.30%
On October 20, 2026, CNC closed at $70.85, up 3.30% from $68.59, on 3.39M shares. The source gives price action but no company-specific catalyst or peer comparison.
Analog Devices and EPC Introduce High-Efficiency GaN-Based Power Converter Reference Design
Analog Devices and EPC have launched the EVAL-LT7930-AZ, a reference design that utilizes GaN technology to support high-power applications.